A drug has blocked the brain process that kills cells in incurable Huntington's disease—and works in human cells.
GRAIL is the only company that has applied for MCED FDA premarket approval so far; if approved by the FDA and covered by ...
By Sneha S K June 30 (Reuters) - U.S. FDA staff reviewers said there is little evidence to allow compounding pharmacies to ...
Gansu Constar Technology Group (Constar), one of China’s leading contact lens manufacturers, is strengthening its position as a trusted global partner by highlighting its robust EU CE (0197) and ISO ...
The Food and Drug Administration will allow Philip Morris International to market Zyn nicotine pouches as presenting a lower health risk than cigarettes. The decision announced Tuesday authorizes 20 ...
The FDA said on Tuesday it would allow Philip Morris to market its Zyn nicotine pouches as less harmful than cigarettes.
Healthcare veteran Dr Douglas Williams discusses the impact of recent political upheaval in the US and the prospect of major ...
Beaumont Occupational Services Offers Certified Drug Testing for Workplaces and Court Requirements Beaumont, United ...
Kriya Therapeutics, Inc. ("Kriya"), a biotechnology company developing durable medicines for chronic diseases, today announced it has been selected by the U.S. Food and Drug Administration (FDA) to ...
MedPage Today on MSN
After Recent Leadership Departures, Is the FDA Returning to Form?
Experts clash over significance of agency's reversals on certain rare disease drugs ...
FDA names companies domestic drug manufacturing pilot participants to enhance early regulatory engagement and streamline review processes.
Orca Bio has jumped into the commercial market with FDA approval for Tregzi, a first-of-its-kind engineered cell therapy for blood cancer patients requiring transplants. | Orca Bio has jumped into ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results